Cell line name |
HT-29R |
Accession |
CVCL_EQ49 |
Resource Identification Initiative |
To cite this cell line use: HT-29R (RRID:CVCL_EQ49) |
Comments |
Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:132984; RO4927350. Derived from site: In situ; Colon; UBERON=UBERON_0001155. |
Sequence variations |
- Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
|
Disease |
Colon adenocarcinoma (NCIt: C4349) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_0320 (HT-29) |
Sex of cell |
Female |
Age at sampling |
44Y |
Category |
Cancer cell line |
Publications | PubMed=21705440; DOI=10.1158/0008-5472.CAN-10-4351 Wang H.-S., Daouti S., Li W.-H., Wen Y., Rizzo C., Higgins B., Packman K., Rosen N., Boylan J.F., Heimbrook D., Niu H.-F. Identification of the MEK1(F129L) activating mutation as a potential mechanism of acquired resistance to MEK inhibition in human cancers carrying the B-RafV600E mutation. Cancer Res. 71:5535-5545(2011) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_EQ49
|
Encyclopedic resources |
Wikidata; Q54896533
|
Polymorphism and mutation databases |
Cosmic; 1889159
|
Entry history |
Entry creation | 26-Sep-2016 |
Last entry update | 05-Oct-2023 |
Version number | 17 |
---|